Literature DB >> 8339013

The poor-responder patient in an in vitro fertilization-embryo transfer program.

Z Ben-Rafael1, D Feldberg.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1993        PMID： 8339013     DOI： 10.1007/bf01207732

Source DB:  PubMed          Journal:  J Assist Reprod Genet        ISSN： 1058-0468            Impact factor:   3.412


× No keyword cloud information.
  15 in total

1.  Differences in ovarian stimulation in human menopausal gonadotropin treated woman may be related to follicle-stimulating hormone accumulation.

Authors:  Z Ben-Rafael; J F Strauss; L Mastroianni; G L Flickinger
Journal:  Fertil Steril       Date:  1986-10       Impact factor: 7.329

2.  An alternate approach to controlled ovarian hyperstimulation in "poor responders": pretreatment with a gonadotropin-releasing hormone analog.

Authors:  P Serafini; B Stone; J Kerin; J Batzofin; P Quinn; R P Marrs
Journal:  Fertil Steril       Date:  1988-01       Impact factor: 7.329

3.  Prediction of response to controlled ovarian hyperstimulation: a comparison of basal and clomiphene citrate-stimulated follicle-stimulating hormone levels.

Authors:  T Tanbo; P O Dale; O Lunde; N Norman; T Abyholm
Journal:  Fertil Steril       Date:  1992-04       Impact factor: 7.329

Review 4.  Insulin-like growth factor I as an intraovarian regulator: basic and clinical implications.

Authors:  E Y Adashi; C E Resnick; E R Hernandez; A Hurwitz; C T Roberts; D Leroith; R Rosenfeld
Journal:  Ann N Y Acad Sci       Date:  1991       Impact factor: 5.691

5.  Outcome of in vitro fertilization in women with low response to ovarian stimulation.

Authors:  A Pellicer; A Lightman; M P Diamond; J B Russell; A H DeCherney
Journal:  Fertil Steril       Date:  1987-05       Impact factor: 7.329

6.  Growth hormone facilitates ovulation induction by gonadotrophins.

Authors:  R Homburg; A Eshel; H I Abdalla; H S Jacobs
Journal:  Clin Endocrinol (Oxf)       Date:  1988-07       Impact factor: 3.478

7.  Ovarian response of individuals to different doses of human menopausal gonadotropin.

Authors:  C A Benadiva; Z Ben-Rafael; J F Strauss; L Mastroianni; G L Flickinger
Journal:  Fertil Steril       Date:  1988-06       Impact factor: 7.329

8.  Prognostic assessment of female fecundity.

Authors:  D Navot; Z Rosenwaks; E J Margalioth
Journal:  Lancet       Date:  1987-09-19       Impact factor: 79.321

9.  Co-treatment with growth hormone of sub-optimal responders in IVF-ET.

Authors:  E J Owen; C West; B A Mason; H S Jacobs
Journal:  Hum Reprod       Date:  1991-04       Impact factor: 6.918

10.  Value of suppression with a gonadotropin-releasing hormone agonist prior to gonadotropin stimulation for in vitro fertilization.

Authors:  K Droesch; S J Muasher; R G Brzyski; G S Jones; S Simonetti; H C Liu; Z Rosenwaks
Journal:  Fertil Steril       Date:  1989-02       Impact factor: 7.329
View more
  7 in total

1.  FSH receptor gene polymorphisms have a role for different ovarian response to stimulation in patients entering IVF/ICSI-ET programs.

Authors:  Dimitris Loutradis; Eleni Patsoula; Vassilis Minas; Giorgos A Koussidis; Aristeidis Antsaklis; Stylianos Michalas; Antonis Makrigiannakis
Journal:  J Assist Reprod Genet       Date:  2006-05-19       Impact factor: 3.412

2.  High FSH:LH ratio and low LH levels in basal cycle day 3: impact on follicular development and IVF outcome.

Authors:  G Barroso; S Oehninger; A Monzó; P Kolm; W E Gibbons; S J Muasher
Journal:  J Assist Reprod Genet       Date:  2001-09       Impact factor: 3.412

3.  Improvement of IVF outcome in poor responders by discontinuation of GnRH analogue during the gonadotropin stimulation phase--a function of improved embryo quality.

Authors:  M Schachter; S Friedler; A Raziel; D Strassburger; O Bern; R Ron-el
Journal:  J Assist Reprod Genet       Date:  2001-04       Impact factor: 3.412

4.  In vitro fertilization with low-dose clomiphene citrate stimulation in women who respond poorly to superovulation.

Authors:  A O Awonuga; A Nabi
Journal:  J Assist Reprod Genet       Date:  1997-10       Impact factor: 3.412

Review 5.  Growth hormone cotreatment with gonadotropins in ovulation induction.

Authors:  P G Artini; A A de Micheroux; G D'Ambrogio
Journal:  J Endocrinol Invest       Date:  1996-12       Impact factor: 4.256

6.  Does pretreatment with progestogen or oral contraceptive pills in low responders followed by the GnRHa flare protocol improve the outcome of IVF-ET?

Authors:  E al-Mizyen; L Sabatini; A M Lower; C M Wilson; T al-Shawaf; J G Grudzinskas
Journal:  J Assist Reprod Genet       Date:  2000-03       Impact factor: 3.412

Review 7.  Evaluation and treatment of low responders in assisted reproductive technology: a challenge to meet.

Authors:  S J Fasouliotis; A Simon; N Laufer
Journal:  J Assist Reprod Genet       Date:  2000-08       Impact factor: 3.412
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.